Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 BEHRENS M KATHLEEN Director Grant or award +1,846 176,839
2024-03-01 BEHRENS M KATHLEEN Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Nicaise Claude Director Grant or award +1,846 18,174
2024-03-01 Nicaise Claude Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Boor Kathryn Jean Director Grant or award +1,846 8,277
2024-03-01 Boor Kathryn Jean Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Barry Richard Director Grant or award +1,846 2,931,688
2024-03-01 Barry Richard Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Mayo Stephen Director Grant or award +1,846 9,756
2024-03-01 Mayo Stephen Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Chambers Michael Andrew Director Grant or award +1,846 8,277
2024-03-01 Chambers Michael Andrew Director Grant or award · Stock Option (right to buy) +3,679 3,679
2024-03-01 Brown Ryan Edward EVP, General Counsel Shares withheld for taxes −269 $126.19 $34K 27,827
2024-03-01 Brown Ryan Edward EVP, General Counsel Grant or award +6,000 33,827
2024-03-01 Brown Ryan Edward EVP, General Counsel Sale −2,000 $125.34 $251K 31,827
2024-03-01 Brown Ryan Edward EVP, General Counsel Grant or award · Stock Option (right to buy) −12,500 12,500
2024-03-01 Rodino-Klapac Louise Head of R&D, CSO Shares withheld for taxes −778 $126.19 $98K 65,222
2024-03-01 Rodino-Klapac Louise Head of R&D, CSO Grant or award +6,000 71,222
2024-03-01 Rodino-Klapac Louise Head of R&D, CSO Grant or award · Stock Option (right to buy) +12,500 12,500
2024-03-01 Arif Bilal Chief Tech Ops Officer Shares withheld for taxes −251 $126.19 $32K 22,836

Page 13 of 22 · 424 trades